The trademark application TOMAYIK was filed by Bristol-Myers Squibb Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on April 26, 2021, and it was registered by office on August 3, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).